A retrospective study of SBRT of metastases in patients with primary sarcoma
Open Access
- 20 July 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Medical Oncology
- Vol. 29 (5), 3431-3439
- https://doi.org/10.1007/s12032-012-0256-2
Abstract
We retrospectively reviewed the results of stereotactic body radiotherapy (SBRT) in 46 patients with a total of 136 metastases from primary sarcoma. The purpose of this study was to evaluate the overall response rate and side effects of SBRT in metastatic sarcoma. The patients were treated at Karolinska University Hospital between 1994 and 2005, using 3D conformal multifield technique and a stereotactic body-frame. Prescribed doses ranged from 4 to 20 Gy per fraction in 1–5 fractions, with total doses of 10–48 Gy. All 46 patients were diagnosed with a primary sarcoma. The treated metastases were localized mainly in the lungs. A total number of 136 metastases were treated (1–14 per patient). Overall response rate (local control = CR, PR and SD) for each tumour was 88 % (119/135). Median follow-up was 21.8 months (range 2.7–112.8 months). Thirteen patients (31 %) were long-term survivors (>36 months), and 5 patients are still alive after last follow-up. Two cases of serious non-lethal side effects were seen, one patient had a colon perforation and another patient had contracture of the hip region. SBRT is a safe, convenient and effective non-invasive treatment with high local control for patients with metastatic sarcoma.Keywords
This publication has 25 references indexed in Scilit:
- Evidence-Based Recommendations for Local Therapy for Soft Tissue SarcomasJournal of Clinical Oncology, 2007
- Locally advanced and metastatic sarcoma (adult type) including gastrointestinal stromal tumorsCritical Reviews in Oncology/Hematology, 2006
- Prospective study on stereotactic radiotherapy of limited-stage non–small-cell lung cancerInternational Journal of Radiation Oncology*Biology*Physics, 2006
- Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer—Mature results for medically inoperable patientsLung Cancer, 2006
- Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countriesActa Oncologica, 2006
- Hypofractionated extracranial stereotactic radiotherapy for liver tumorsInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Reporting and analyzing dose distributions: A concept of equivalent uniform doseMedical Physics, 1997
- Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patientsActa Oncologica, 1995
- Stereotactic Radiotherapy of Malignancies in the Abdomen: Methodological aspectsActa Oncologica, 1994
- The linear-quadratic formula and progress in fractionated radiotherapyThe British Journal of Radiology, 1989